Strategic partnerships The IMF collaborates with research networks like IMWG and engages in partnerships (eg SparkCures) to advance clinical trials and patient access, presenting opportunities for technology, data sharing, or sponsor alignment with trial initiatives.

donor and fundraising growth With revenue in the 10-25M range and a strong fundraising ecosystem (events like Iceland Cycling Expedition and 5K Runs), there is potential for expanded sponsorships, donor management tools, and digital fundraising platforms.

Patient engagement Global support networks, 24/7 AI assistant Myelo, InfoLine services, and education programs indicate demand for patient-centric tech, telehealth, CRM-enabled care navigation, and AI-driven patient outreach.

Clinical trial access IMF’s focus on increasing trial participation and iStopMM initiatives signals opportunities to offer trial matching platforms, data integration, and patient recruitment solutions to improve eligibility screening and enrollment.

Thought leadership As the leading myeloma organization with the IMWG guidelines influence, IMF presents opportunities for sponsored education content, conference partnerships, and enterprise-grade content management or analytics for guideline dissemination.